Skip to main content

Selecting Medications for Epilepsy, Therapeutic Drug Monitoring and Drug Taper

       
Michael R. Sperling, MD

Michael R. Sperling, M.D., is Baldwin Keyes Professor of Neurology and Vice Chair for Research at the Sidney Kimmel Medical College at Thomas Jefferson University, and Director of the Jefferson Comprehensive Epilepsy Center. He is an internationally recognized clinician-scientist in the field of epilepsy, known particularly for his work in clinical neurophysiology, epilepsy surgery, and investigational therapeutics. He has published approximately 500 peer-reviewed papers, reviews, and book chapters, and several books. He is presently Editor-in-Chief of Epilepsia and is a former president of the American Clinical Neurophysiology Society and the Philadelphia Neurological Society. He received the J. Kiffin Penry award from the American Epilepsy Society in 2018 and the Ambassador for Epilepsy award from the International League Against Epilepsy in 2021.
Start Pre Test

Session:
Selecting Medications for Epilepsy, Therapeutic Drug Monitoring and Drug Taper

Course Description:
This educational presentation will use lecture and various case examples to illustrate that most epileptic seizures are worth treating. This discussion will review risk factors throughout the illness, the elements of pharmacotherapy and expected responses to medication. Issues with adherence to therapy and relapse risk after medication is discussed.

Learning Objectives:
  • Choose appropriate antiseizure medication for patients with epilepsy, tailoring the choice to patient co-morbidities and demographic characteristics using free, on-line tools.
  • Discuss the utility of therapeutic drug monitoring and apply this in clinical practice for patient management.
  • Assess the chance of relapse if antiseizure medication is discontinued and appropriate counsel patients on the need for therapy.

To receive a Continuing Medical Education certificate, take the pre-test, attend the presentation, complete the post-test, and the post-presentation evaluation.